PolyU collaborates with Axis Therapeutics to establish joint laboratory for immunotherapy (IMAGE)
Caption
Mr Yonghui Wang said that the collaboration with PolyU will further enable Axis to conduct clinical trials in Hong Kong and benefits patients in the city. Moving forward, Axis will collaborate with PolyU in the development of up to 30 further targeting biologics, which could be adapted into novel cell therapy of the future.
Credit
© 2024 Research and Innovation Office, The Hong Kong Polytechnic University. All Rights Reserved.
Usage Restrictions
Nil
License
Original content